Amedisys (NASDAQ:AMED) Sees Unusually-High Trading Volume - Should You Buy?

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 893,598 shares traded hands during trading, an increase of 167% from the previous session's volume of 334,064 shares.The stock last traded at $96.94 and had previously closed at $94.22.

Analysts Set New Price Targets

AMED has been the topic of several research reports. Royal Bank of Canada reiterated an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday, April 16th. Wall Street Zen lowered Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Finally, Stephens reissued an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $100.75.

Amedisys Trading Up 0.0%

The company has a market cap of $3.18 billion, a price-to-earnings ratio of 38.44, a price-to-earnings-growth ratio of 1.78 and a beta of 0.94. The company's 50 day moving average price is $93.74 and its 200 day moving average price is $91.80. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.12. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. During the same period last year, the company earned $1.03 earnings per share. The business's revenue was up 4.1% compared to the same quarter last year. Research analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current year.

Institutional Investors Weigh In On Amedisys

Hedge funds and other institutional investors have recently made changes to their positions in the business. MassMutual Private Wealth & Trust FSB boosted its stake in Amedisys by 56.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after purchasing an additional 120 shares during the period. Blue Trust Inc. lifted its holdings in shares of Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after buying an additional 124 shares during the last quarter. Fifth Third Bancorp boosted its position in shares of Amedisys by 68.1% in the first quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after acquiring an additional 141 shares during the period. Xponance Inc. grew its stake in shares of Amedisys by 3.5% in the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after acquiring an additional 148 shares during the last quarter. Finally, Gamco Investors INC. ET AL increased its position in Amedisys by 0.5% during the fourth quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock worth $2,754,000 after acquiring an additional 159 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.